SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is trending following news of a strategic manufacturing partnership aimed at significantly reducing production costs and expanding capacity, which has driven substantial intraday stock volatility. The community is actively discussing the stock's low float and high trading volume, fueling speculation about a potential short squeeze and anticipating further upward movement as it tests key resistance levels. This partnership is seen as a crucial step for scaling their fingerprint drug screening technology ahead of anticipated future market expansion.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending due to recent discussions surrounding its integration as a fuel-discount token within the EzFill app, generating buzz about its expanding utility. The community is sharply divided, with many anticipating significant future appreciation from multi-year lows and viewing it as "digital silver," while others express frustration over its recent price action and struggle to overcome key resistance levels.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is currently a focal point for year-end tax loss selling, leading to sharp price movements and a polarized community discussion. Many foresee further declines for the meme coin, while a resilient group of long-term holders views the current dip as a strategic accumulation opportunity for future crypto cycles, with eyes on a potential rally in 2026.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending significantly following the FDA approval of NEREUS, marking the first new pharmacologic treatment for motion-induced vomiting in over four decades. The community is actively discussing the drug's potential beyond motion sickness, particularly its vast opportunity in addressing GLP-1 induced nausea, which many see as a transformative revenue driver for the company. With analysts raising price targets and whispers of potential buyout interest, investors anticipate continued upside as the market fully prices in this key regulatory win and the company's robust pipeline.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp (ESHA) is trending within a volatile low-float SPAC sector, fueled by discussions surrounding its extremely tight share float and high insider ownership. The community is actively debating its potential for rapid price movement and a short squeeze, drawing comparisons to other recently surging SPACs as new utility via a planned reward token is also highlighted.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics (CORT) is trending with significant volatility after receiving an FDA Complete Response Letter for its relacorilant drug, triggering a sharp decline in shares. The community is fiercely divided, with many calling the sell-off an overreaction given the company's existing profitable drug and deep pipeline, while others foresee further downside following analyst downgrades and a need for more clinical evidence. This binary regulatory event has intensified speculation, as investors weigh potential recovery against lingering uncertainty.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending following the FDA's acceptance and priority review of AXS-05 for Alzheimer's disease agitation, alongside positive feedback supporting an upcoming NDA for AXS-12 in narcolepsy. The market is reacting strongly to this dual pipeline advancement, with community members expressing high optimism and noting significant short-covering as a key driver of the momentum.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending after a competitor's drug for Cushing's syndrome received a regulatory setback from the FDA, which the community views as a significant advantage for Xeris's approved treatment, Recorlev. This development is seen as clearing the path for Recorlev to gain market share, fueling discussions among investors about the company's long-term growth potential and undervaluation, supported by positive analyst outlooks.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is highly active following the CME Group's recent, repeated increases in margin requirements for silver futures, sparking intense debate among traders who see it as a desperate measure to control a surging market. This volatility is further fueled by conflicting narratives around impending Chinese silver export restrictions and the growing disconnect between paper and physical prices. The community is sharply divided between those predicting a massive short squeeze driven by industrial demand and global supply shifts, and those anticipating a significant pullback.

Alchemy Investments Acquisition Corp. 1 is a blank check company, which engages in merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination. The company was founded on October 27, 2021 and is headquartered in Newark, DE.

Alchemy Investments Acquisition Corp 1 - Ordinary Shares - Class A

ALCY is attracting considerable attention, primarily driven by its status as a low-float SPAC, leading to strong comparisons with other recent tickers that have seen significant, swift price movements. The community is actively discussing "dip buys" and speculating on potential upside, with many anticipating a continuation of the "low float SPAC bubble" trend while also acknowledging the inherent risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

(Photo credit should read INDRANIL MUKHERJEE/AFP via Getty Images)

One Chinese EV Stock Surged 80% In 2025 – But Two Others Told Very Different Stories

XPeng was the top performer in 2025, with gains of around 80%, while Li Auto’s stock declined 28% YTD.

XPeng, Nio, Li Auto Stocks Diverge Sharply In 2025: Here’s What Investors Are Watching Next

Equity

Morgan Stanley Downgrades Tesla: Should You Revisit Your EV ETF Portfolio?

Tesla's downgrade and shrinking EV share spotlight the value of diversification as EV ETFs like KARS offer broader, steadier exposure amid market shifts.  

<ul class="summary-bullets"><li>The Cybertruck saw the light of day only four years after Musk announced it.</li><li>Before its launch, it had 2 million preorders, underscoring early interest in the vehicle.</li><li>While Musk once touted the Cybertruck as a 250,000-unit-per-year opportunity, third-party sales estimates show it hasn't come anywhere close to that.</li></ul>Elon Musk can't stop raving about Tesla's electric pickup truck, the Cybertruck, just like a creator enamored with the work of his hands. For the umpteenth time on Thursday, he&nbsp;touted its virtues on X, the social-media platform he owns. This time around, he called the Cybertruck an<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/elonmusk/status/1996484482514428311">&nbsp;"incredible vehicle"</a> and the "best-ever from Tesla."Has the vehicle done well to earn the rave reviews? Its contribution to Tesla's sales volume has been so insignificant that Tesla has chosen not to break it down, even two years after its commercial rollout. The company continues to club it under "Other Models," which together accounted for 3.3% of the third-quarter deliveries reported in October.&nbsp;Before assessing the Cybertruck's impact, or lack thereof, on Tesla and its stock, it's worth revisiting how the vehicle came to be.<h2 class="st-heading-2">Hype That Fizzled</h2>The earliest memory many Cybertruck fans share is of chief designer Franz von Holzhausen hurling a metal ball at its "armor glass" in 2019 to prove its toughness — only for the window to crack in a now-infamous viral moment.The Cybertruck saw the light of day only four years after Musk announced it. The first production versions rolled out from Giga Texas and were handed out to customers on Nov. 30, 2023. Ford's F-150 Lightning pickup truck, GMC Hummer, Chevrolet Silverado, Lordstown's Endurance, and Rivian's R1T were&nbsp;already on sale by then.&nbsp;Endurance's production has since stopped amid the startup's manufacturing woes, which led to a Chapter 11 bankruptcy filing in 2023. Rumor has it that Ford is planning to pull the plug on its F-150 Lightning due to mounting losses at its EV business.When the Cybertruck launched, it came in four variants: a single-motor rear-wheel-drive (RWD) model, a dual-motor all-wheel-drive (AWD) version, a tri-motor 'Cyberbeast' performance model, and a foundation-series launch edition.While Musk once touted the Cybertruck as a 250,000-unit-per-year opportunity, third-party sales estimates show it hasn't come anywhere close to that.<figure class="image"><img style="aspect-ratio:600/371;" src="https://news.stocktwits-cdn.com/Tesla_s_Cybertruck_Sales_in_units_png_1bf031d6ed.webp" alt="Tesla's Cybertruck Sales (in units).png" width="600" height="371"></figure>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Data sourced from Shop4Tesla and Tesla Fox&nbsp;<h2 class="st-heading-2">TSLA Stock Tepid</h2><a href="https://stocktwits.com/symbol/TSLA">Tesla's stock</a> languished for about a year after the Cybertruck launch, lagging the broader market. Although the stock staged a comeback in late 2024 and rallied strongly through year-end, it pulled back again amid the market-wide tariff sell-off. It has since then recovered. Neither the post-Cybertruck launch stock weakness nor the recovery seen in spurts since can be traced back to the vehicle. However, the cybertuck hasn't given the stock meaningful thrust.<img src="https://news.stocktwits-cdn.com/Tesla_stock_png_2a632213ac.webp" alt="Tesla stock.png">Source: KoyfinThe oddly designed vehicle was once seen as a key catalyst for Tesla. Fund manager and Tesla investor Gary&nbsp;Black said in a 2023 CNBC interview, "People going to see it, they'll be like, wow!" he said, adding that people will go to the website and order a Model 3, Model Y, Model S, or even a Cybertruck.He was probably misled by the staggering 2 million preorders it has managed to collect before its launch. Celebrity endorsements and their purchases did very little to boost demand for the vehicle, as the electric vehicle market has been in a downward spiral since its launch. As consumers balked at the high EV ownership, this pricier vehicle did not find favor with them, as they began tightening their purse strings amid an inclement macroeconomic climate.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:<a href="https://stocktwits.com/news-articles/markets/equity/jensen-huang-thinks-we-ll-all-run-our-own-mini-nuclear-reactors-in-our-backyards-amid-ai-power-crunch/cLILvtvRESK">&nbsp;Jensen Huang Thinks We'll All Run Our Own Mini Nuclear Reactors In Our Backyards — What Today's AI Power Crunch Really Looks Like</a>

The sun rises on a Tesla Cybertruck as it drives next to the Hudson River on October 31, 2024, in Weehawken, New Jersey. (Photo by Gary Hershorn/Getty Images)

Elon Musk Calls Cybertruck The 'Best Ever' Vehicle From Tesla — But Its Flashiest EV Still Hardly Moves The Needle

When the Cybertruck finally hit the road after four years of anticipation, it was pitched as a game-changer that would turbocharge Tesla's next phase of growth, but its sales trickled off to anemic levels.

IEA Predicts 20M Electric Car Sales in 2025: ETFs Poised to Gain

DRIV and KARS stand out as EV-focused ETFs are poised to benefit from the IEA's forecast of more than 20M electric car sales in 2025.  

Tesla, Inc.’s (TSLA) underperforming stock came under further pressure in extended trading on Wednesday after a double miss, punctuated by weakness at the electric-vehicle maker’s automotive business.Tesla was among the top five trending tickers on Stocktwits late Wednesday, with retail sentiment nose-diving to ‘bearish’ territory (35/100) by late Wednesday from the ‘neutral’ mood seen a day ago.As retail traders discussed the results, the message volume increased to ‘high’ levels.<figure class="image"><img style="aspect-ratio:618/54;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_23_at_11_51_47_PM_png_aa1bb08cae.webp" alt="Screenshot 2025-07-23 at 11.51.47 PM.png" width="618" height="54"><figcaption>TSLA sentiment and message volume as of 11:50 p.m. ET, July 23 | source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/TSLA">Tesla stock</a>, which has lost nearly 18% year-to-date, fell 4.39% in overnight trading.&nbsp;Key numbers from the quarterly report for the second quarter of the second quarter of 2025 are as follows:<ul style="list-style-type:disc;"><li>Adjusted earnings per share (EPS): $0.40 vs. $0.52 year-ago</li><li>Revenue: $22.50&nbsp;billion vs. $25.50&nbsp;billion (down 12% YoY)</li><li>Automotive revenue: $16.66&nbsp;billion vs.$19.88&nbsp;billion (down 16% YoY)</li><li>Energy generation &amp; Storage: $2.79&nbsp;billion vs. $3.01&nbsp;billion (down 7% YoY)</li><li>Gross margin: 17.2% vs. 18%</li></ul>&nbsp;The adjusted EPS trailed the Fiscal.ai-compiled consensus of $0.41, but revenue beat the mean analysts’ estimate of $22.13 billion.The YoY revenue drop, the biggest since the third quarter of 2012,&nbsp; came about due to declines in EV deliveries and the average selling price, as well as lower regulatory credit. The company stated that these factors impacted profitability, along with higher operating expenses related to artificial intelligence (AI) and other research and development (R&amp;D) projects.On the earnings call, CFO Vaibhav Taneja flagged potential adverse&nbsp;effects for the energy business from President Donald Trump’s “one big, beautiful” bill (through expiration of energy credit) and tariffs.In a statement, Tesla said, “Q2 2025 was a seminal point in Tesla’s history: the beginning of our transition from leading the electric vehicle and renewable energy industries to also becoming a leader in AI, robotics, and related services.”The company stated that it had produced its first builds of the more affordable version in June, with volume production expected in the second half of 2025. The Tesla Semi and&nbsp;Cybercab (a two-passenger, fully autonomous EV designed for the robotaxi service) are slated for volume production in 2026.Offering an update on the robotaxi launch, CEO Elon Musk stated on the earnings call that the company would “greatly increase” the Austin service area&nbsp;beyond what&nbsp;the competition is doing in a couple of weeks, according to a Transcript made available&nbsp;by Koyfin.He also flagged the likelihood of securing regulatory permission to launch in the Bay Area, Nevada, Arizona, Florida, and&nbsp;several other locations.Comparing robotaxi service with Alphabet, Inc.’s (GOOGL) Waymo, Musk said, “Tesla is actually much better than Google by far and … anyone at real-world AI.”&nbsp;&nbsp;Alphabet CEO Sundar Pichai, meanwhile, said on the company’s earnings call that Waymo “launched in Atlanta, more than doubled its Austin service territory, and expanded its Los Angeles and San Francisco Bay Area territories by approximately 50%.”Pichai also said the company is testing across more than 10 cities this year, including New York and Philadelphia.Retail chatter around Tesla earnings was bordering on bearishness. One user braced for a “bloodbath” on Thursday.<stembedurl>https://stocktwits.com/SirBullsAlot/message/622216373</stembedurl>Pointing to Musk’s comments on the earnings call about the next few quarters being rough, a user questioned the logic behind people buying the stock.<stembedurl>https://stocktwits.com/Guntz/message/622213772</stembedurl>While answering analysts’ questions, Musk said the next few quarters, probably up to the second quarter of 2025, could be rough. “But once you get to autonomy at scale in the second half of next year, certainly by the end of next year, I think I would be surprised if Tesla's economics are not very compelling,” he added.The Koyfin-compiled consensus price target of $305.05 for the Tesla stock implies further downside (8.27%) from Wednesday’s close.For updates and corrections, email newsroom[at]stocktwits[dot]com.Editor's note: This copy has been updated to clarify that Tesla began production of its more affordable models in June.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/alphabet-ceo-sundar-pichai-hails-standout-q2-as-ai-powers-growth-across-divisions/ch8yiiLR5ua">Alphabet CEO Sundar Pichai Hails ‘Standout’ Q2 As AI Powers Growth Across Divisions — Retail Cheers Rising Google Search Momentum</a>

In this photo illustration, a Tesla logo is seen displayed on a smartphone with the image of Elon Musk in the background. 

Elon Musk Warns Of ‘Rough’ Quarters Ahead For Tesla, But ‘Affordable’ EV Hopes Cushion Stock Slide: Retail Mood Nosedives 

The YoY revenue drop, the biggest since the third quarter of 2012,  came about due to declines in EV deliveries and the average selling price, as well as lower regulatory credit.

Tesla, Inc. (TSLA) shares edged up in Wednesday’s early premarket session ahead of the electric vehicle (EV) maker’s earnings report due after the market close.Stung by a demand slowdown amid macroeconomic uncertainties, and CEO Elon Musk’s political overtures and concerns over his divided attention to his flagship business,&nbsp;<a href="https://stocktwits.com/symbol/TSLA">Tesla stock</a> is down nearly 18% for the year. This contrasts with the S&amp;P 500’s 8% advance over the same period.The stock, which is part of the Magnificent Seven group of mega-cap companies, is the&nbsp;worst-performing among them. The<a href="https://stocktwits.com/symbol/MAGS"> Roundhill Magnificent Seven ETF (MAGS)</a>, an exchange-traded fund (ETF) that tracks the performance of these seven stocks, has gained 5.46% year-to-date.According to Fiscal.ai-compiled consensus, Tesla is expected to report adjusted earnings per share (EPS) of $0.41 and revenue of $22.13 billion for the second quarter of the fiscal year 2025&nbsp;versus the year-ago quarter’s $0.40 and $25.5 billion, respectively. However, the metrics are expected to improve from the first quarter’s $0.27 and $19.34 billion, respectively.Earlier this month, Tesla reported vehicle deliveries of 384,122 units for the second quarter, down sharply from the year-ago’s 443,956 units but up from 336,681 units reported for the previous quarter.Investors are likely to look past the second-quarter numbers and focus on Tesla’s update on the robotaxi rollout.&nbsp;Questions compiled by the shareholder services platform provider Say, on behalf of Tesla investors, showed that those representing 2.9 million Tesla shares wanted information on “how robotaxis have been performing so far and what rate they are expected to expand in terms of vehicles, geofence, cities, and supervisors.”Tesla launched the service in Texas last month to mixed reviews.In a note released on Tuesday, Roth Capital stated that the positives at&nbsp;Robotaxi and Optimus are likely to outweigh the weakness in second-quarter EV sales, as reported by The Fly. The firm has assigned a ‘Buy’ rating and a $395 price target to Tesla stock.BofA Securities raised&nbsp;Tesla's stock price target to $314 from $305 this week but maintained a ‘Neutral’ rating. The firm sees a challenging second quarter due to Trump tariffs and the disappointing second-quarter deliveries.&nbsp;The focus is also likely to be on the impact of the Trump administration’s decision to eliminate the federal tax credit for EVs.&nbsp;On Stocktwits, sentiment toward Tesla stock was at ‘neutral’ (53/100) early Wednesday, with the message volume staying at ‘normal’ levels.<figure class="image"><img style="aspect-ratio:623/51;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_23_at_5_46_59_AM_png_a96248b552.webp" alt="Screenshot 2025-07-23 at 5.46.59 AM.png" width="623" height="51"><figcaption>TSLA sentiment and message volume as of 5:40 a.m. ET, July 23 | source: Stocktwits</figcaption></figure>A bearish watcher called upon fellow retail traders to short the stock, fearing a “bad” earnings report.<stembedurl>https://stocktwits.com/BennyBoy18/message/622045171</stembedurl>However, a bullish user&nbsp;suggested that Tesla stock could move in tandem with its overseas auto peers, reacting to the Japan trade deal, and potentially rise ahead of earnings.&nbsp;<stembedurl>https://stocktwits.com/Okadarlan/message/622046056</stembedurl>The Koyfin-compiled consensus price target for Tesla stock is $305.05, implying roughly 8% downside from current levels.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/abivax-spikes-460-percent-on-positive-late-stage-ulcerative-colitis-drug-trial-results/ch8wSLiR5MQ">Small-Cap Abivax Spikes 400% On Positive Late-Stage Ulcerative Colitis Drug Trial Results — Retail Buzz Builds Around Blockbuster Potential</a>

A lineup of various Tesla models on display at the Edmonton Motor Show on April 13, 2025, in Edmonton, Alberta, Canada. 

Tesla Earnings Ahead: Can Robotaxi Hype Offset Q2 Auto Woes?

According to Fiscal.ai-compiled consensus, Tesla is expected to report adjusted earnings per share of $0.41 and revenue of $22.13 billion for the second quarter of the fiscal year 2025.

Barclays: China’s EV dominance grows as Western demand and policy falter

Investing.com -- China’s dominance in the electric vehicle (EV) sector is widening as policy headwinds and cooling demand continue to weigh in on the market in the U.S. and Europe, according to Barclays, citing BloombergNEF’s (BNEF) latest EV Outlook.

Tesla, Inc. (TSLA) stock experienced one of its biggest drawdowns, which shaved nearly $154 billion from the Elon Musk-led electric vehicle (EV) company’s market capitalization.Musk, the world’s richest person, saw his net worth drop by roughly $34 billion, as a large portion of his wealth is linked to his electric vehicle company.Musk-Trump Lock HornsThe development came after Musk and President Donald Trump exchanged tirades on social media, days after the former exited from the Department of Government Efficiency (DOGE) — a quasi-governmental agency set up by the latter immediately after he was sworn in as president.The DOGE was established to&nbsp;identify and eliminate wasteful government expenditures, aiming to reduce the ballooning U.S. fiscal deficit.&nbsp;While leaving the DOGE in a public ceremony in the White House, the two professed longlasting camaraderie.Things took a turn for the worse&nbsp;within a week. The feud started when Musk raised objections to Trump's “one, big, beautiful bill,’ calling it a “disgusting abomination.” On Thursday, Musk intensified his attack by posting on X, a social-media platform he owns, that the president wouldn’t have won a second term without his support.&nbsp;Trump did not take kindly to the comment. Calling Musk “crazy,” the president threatened&nbsp;to cancel the federal contracts of the companies owned by him. Apart from his flagship EV venture, Musk also runs SpaceX, Neuralink brain implant company, Boring Company, X, and the xAI artificial intelligence (AI) startup.He also&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://truthsocial.com/@realDonaldTrump/posts/114632205177163456">said</a> Musk’s belligerent attitude was due to his administration cancelling his EV mandate. Trump’s tax bill&nbsp;includes a provision to cancel the Biden administration's EV tax credit.Musk went one up and said he would decommission all key Dragon spacecraft that are&nbsp;crucial&nbsp;for the International Space Station. In a separate post, he also said Trump’s name is in the infamous “Epstein files,” adding that it was the reason why they haven’t been made public.In the interim, Musk ran a&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/elonmusk/status/1930685402631053403">poll&nbsp;</a>asking his over 220 million followers whether it was time to create a new political party in America that actually represents the 80% in the middle. At the time of writing, over 80% had replied in the affirmative.Amid heated social media exchanges that intensified on Thursday afternoon, Tesla plummeted to a low of $273.21 before closing down 14.26% at $284.70.Analyst WorriedCommenting on the stock drop, Wedbush analyst Daniel Ives said it was due to investor fears that “this Musk/Trump battle will stop their friendship and change the regulatory environment for Tesla on the autonomous front over the coming years under the Trump Administration.”“The quickly deteriorating friendship and now "major beef" between Musk and Trump is jaw dropping and a shock to the market and putting major fear for Tesla investors on what is ahead,” he added.Ives, however, expressed hopes of the situation starting to settle down, adding that it wasn’t good for either side.The analyst said, “This feud does not change our bullish view of Tesla and the autonomous view, but clearly does put a fly in the ointment of the Trump regulatory framework going forward.”“ It's another Twilight Zone moment in this Musk/Trump relationship which now is quickly moving downhill.”Retail DownbeatOn Stocktwits, retail sentiment toward&nbsp;<a href="https://stocktwits.com/symbol/TSLA">Tesla stock</a> stayed at ‘extremely bearish’ levels (5/100) by late Thursday, with the degree of intensifying sharply from a day ago. The message volume on the Tesla stream was ‘extremely high.’<figure class="image"><img style="aspect-ratio:620/56;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_05_at_10_09_43_PM_png_02ad02e826.webp" alt="Screenshot 2025-06-05 at 10.09.43 PM.png" width="620" height="56"><figcaption>TSLA sentiment, message volume as of 10:10 p.m. ET, June 5 | source: Stocktwits</figcaption></figure>The EV maker’s stock was the top trending and the most active ticker on the platform by late Thursday.A user expected further bloodbath in Tesla stock as they eyed the May non-farm payrolls report.<stembedurl>https://stocktwits.com/mag7btcbull/message/617021475</stembedurl>Another user&nbsp;predicted that the stock&nbsp;would drop to $250 or below if the feud intensifies.<stembedurl>https://stocktwits.com/Bill164/message/617021293</stembedurl>An ongoing&nbsp;<a href="https://stocktwits.com/StocktwitsPolls/message/616958799">Stocktwits poll&nbsp;</a>that asked users whether the Musk-Trump fallout has changed their view on the Tesla stock found that a majority (52%) has turned bearish.Tesla stock has lost about 30%, including the plunge on Thursday, as the EV business struggles amid economic uncertainties. Musk hasn’t helped its cause by focusing on the DOGE and his other ventures.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Tesla CEO Elon Musk and U.S. President Donald Trump listen to a question from reporters in the Oval Office of the White House on May 30, 2025.

Musk-Trump Showdown Melts Tesla Stock, Dents Billionaire’s Net Worth: As Analyst Calls It ‘Twilight Zone,’ Retail Holds Depressed View

Musk, the world’s richest person, saw his net worth drop by roughly $34 billion, as a large portion of his wealth is linked to his electric vehicle company.

Musk-Trump Showdown Melts Tesla Stock, Dents Billionaire’s Net Worth

Musk, the world’s richest person, saw his net worth drop by roughly $34 billion, as a large portion of his wealth is linked to his electric vehicle company.


Elon Musk's brain implant company Neuralink announced Monday a $650 million capital raise in a new funding round, while his artificial intelligence (AI) venture xAI has reportedly opted for a debt offering.The development came shortly after the Tesla CEO&nbsp;confirmed his exit from the Department of Government Efficiency (DOGE), which took up&nbsp;much of the billionaire’s time.&nbsp;Investors, including Sequoia Capital, Thrive Capital, Peter Thiel’s Founders Fund, Lightspeed Venture Partners and Cathie Wood’s Ark Investment&nbsp;Management participated in Neuralink’s Series E funding round.Neuralink said that since its Series D financing in August 2023, its brain implant has been used by five individuals with severe paralysis, and global clinical trials have been launched for neurosurgical care spanning three countries and two continents.The Series D financing raised $280 million from investors such as Founders Fund.&nbsp;The Musk-backed company has also launched a trial, dubbed CONVOY, to test out new use cases beyond digital device control. Additionally, it has invested heavily in expanding the number of neurons and brain regions that our device interfaces with to unlock new dimensions of human potential.Neuralink’s brain-computer interface (BCI) product, the N1 implant, is designed to record neural activity through 1,024 electrodes distributed across 64 flexible leads, or “threads.” Each of these threads are thinner than a human hair and can be placed independently in the brain.The company said the five individuals with severe paralysis who use Neuralink&nbsp;can now control digital and physical devices with their thoughts, marking a profound step toward helping restore independence.BCI research is gaining momentum, with Neuralink’s rival and startup, Paradromics, testing its device, Connexus, in its first human patients in May.&nbsp;Last month, Synchron, a New York-based medical equipment manufacturer, announced&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/apple-steps-into-elon-musk-neuralink-territory-with-brian-control-tech/chiqLaIRbZy">teaming up</a> with Apple (APPL), allowing the latter to add a new protocol to support "Switch Control" for BCI in its hardware devices.Separately, a Bloomberg report citing people familiar with the matter said Musk-owned xAI has roped in Morgan Stanley to raise $5 billion in debt. The interest rate for the debt will be in double digits.The fund will likely help the startup build&nbsp;xAI’s ambitious Memphis data center.The debt offering has already generated demand for over $3.5 billion.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/snowflake-aims-to-boost-ai-offerings-with-250-m-deal-for-crunchy-data/chkAysbRbvG">Snowflake Aims To Boost AI Offerings With $250M Deal For Crunchy Data — Retail Traders Upbeat</a>

 Elon Musk listens as President Trump speaks to reporters in the Oval Office of the White House on May 30, 2025 in Washington, DC. Musk, who served at DOGE, left his role in the Trump administration early this week to refocus on his businesses. 

Elon Musk’s Neuralink, xAI Speed Up Fundraising Plans After Tesla CEO’s DOGE Exit

Neuralink’s brain-computer interface (BCI) product, dubbed the N1 implant, is designed to record neural activity through 1,024 electrodes distributed across 64 flexible leads, or “threads.”

BofA sees more impact on China auto part makers than auto OEMs from tariff hike

Investing.com -- The Trump administration last week introduced a 34% tariff hike on imports from China, a measure that comes on top of the 20% hike implemented earlier this year. The latest tariff increase is set to come into effect on April 9.

KARS
Krane Shares Trust - KraneShares Electric Vehicles and Future Mobility Index ETF

Feed

News

Sentiment

Fundamentals

Info

Latest KARS News

KARSKrane Shares Trust - KraneShares Electric Vehicles and Future Mobility Index ETF